WebMay 9, 2016 · Dicerna Pharmaceuticals, Inc., is an RNA interference-based biopharmaceutical company focused on the discovery and development of innovative treatments for rare, inherited diseases involving the liver, for other therapeutic areas in which the liver plays a key role, and for cancers that are genetically defined. WebThere are no current stakeholders of Dicerna Pharmaceuticals. This is normal when the security: Has been acquired or taken private; Has merged with another entity; Has changed its name and has a new CUSIP (and/or symbol) Has been delisted and the ticker has changed; Please use Search to find the security you were looking for.
Dicerna Announces Boehringer Ingelheim’s Acceptance of …
WebDicerna Pharmaceuticals Inc (DPL.BE) Stock Price, News, Quote & History - Yahoo Finance. U.S. markets open in 9 hours 2 minutes. WebDicerna Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery and development of treatments for rare, chronic liver, cardiovascular, and viral infectious … pool car for business
Dicerna Pharmaceuticals : Announces Results for PHYOX™4, …
WebApr 11, 2024 · Alexion Pharmaceuticals, Inc. has collaboration and license agreement with Halozyme Therapeutics, Inc.; and agreements with Dicerna Pharmaceuticals, Inc., Zealand Pharma A/S, Caelum Biosciences, Inc., Stealth BioTherapeutics Corp., and Affibody AB. The company was founded in 1992 and is headquartered in Boston, … WebAug 6, 2024 · Dicerna Pharmaceuticals Drops on Mixed Drug-Trial Results Dicerna Pharma in the fourth quarter expects to submit to the FDA a new-drug application for a … WebMay 3, 2024 · Dicerna Pharmaceuticals (DRNA) to Report Q2 Results: Wall Street Expects Earnings Growth. 07/29/21-2:04PM EST Zacks. More Zacks News for DRNA ». … pool cartridge cleaner bunnings